Texas Life Science Forum: 4M Therapeutics is aiming make therapies for the CNS that are safer and more tolerable than current treatments
CEO Pablo Lapeurta, previously CMO of Lexicon, describes the lead programs for biopolar disorder and Alzheimer's agitation. Plus, Houston as a biotech hub for therapeutics areas beyond oncology, like neuroscience.
Brought to you by